Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemic

Human respiratory syncytial virus (RSV) is a major cause of acute respiratory infection. In 2020, RSV was eliminated from New Zealand due to non-pharmaceutical interventions (NPI) used to control the spread of SARS-CoV-2. However, in 2021, following a brief quarantine-free travel agreement with Australia, there was a large-scale nationwide outbreak of RSV that led to reported cases more than five-times higher than typical seasonal patterns. We generated 1470 viral genomes of both RSV-A and RSV-B sampled between 2015-2022 from across New Zealand. Using a phylodynamics approach, we used these data to better understand RSV transmission patterns in New Zealand prior to 2020, and how RSV became re-established in the community following the relaxation of COVID-19 restrictions. We found that in 2021, there was a large epidemic of RSV due to an increase in importations, leading to several large genomic clusters of both RSV-A ON1 and RSV-B BA9 genotypes. However, while a number of viral importations were detected, there was also a major reduction in RSV genetic diversity compared to pre-pandemic years. These data reveal the impact of NPI used during the COVID-19 pandemic on other respiratory infections and highlight the important insights that can be gained from viral genomes.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2024-11-11
DOI
https://doi.org/10.1038/s41467-024-53998-5
Citations
7
Primary Topic
Respiratory viral infections research
Type
article
Field-Weighted Citation Impact
2.71

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemic

Timothy J. Wood, Chor Ee Tan, Peter McIntyre, Meaghan O’Neill et al.
7 citations
Nature Communications
Respiratory viral infections research
2.71
article

Spatial and temporal transmission dynamics of respiratory syncytial virus in New Zealand before and after the COVID-19 pandemic

Timothy J. Wood, Chor Ee Tan, Peter McIntyre, Meaghan O’Neill, Jing Wang, Nayyereh Aminisani, Klarysse Berquist, A. C. M. Claasen, David Welch, Tineke Jennings, Nikki Turner, Tony Dowell, Lauren Jelley, Helen Johnston, Srushti Utekar, Adrian Trenholme, Jordan Douglas, Joep de Ligt, Catherine A. Byrnes, Ruth Seeds, Judy Bocacao, M. Allais
article en
7 citations

Abstract

Human respiratory syncytial virus (RSV) is a major cause of acute respiratory infection. In 2020, RSV was eliminated from New Zealand due to non-pharmaceutical interventions (NPI) used to control the spread of SARS-CoV-2. However, in 2021, following a brief quarantine-free travel agreement with Australia, there was a large-scale nationwide outbreak of RSV that led to reported cases more than five-times higher than typical seasonal patterns. We generated 1470 viral genomes of both RSV-A and RSV-B sampled between 2015-2022 from across New Zealand. Using a phylodynamics approach, we used these data to better understand RSV transmission patterns in New Zealand prior to 2020, and how RSV became re-established in the community following the relaxation of COVID-19 restrictions. We found that in 2021, there was a large epidemic of RSV due to an increase in importations, leading to several large genomic clusters of both RSV-A ON1 and RSV-B BA9 genotypes. However, while a number of viral importations were detected, there was also a major reduction in RSV genetic diversity compared to pre-pandemic years. These data reveal the impact of NPI used during the COVID-19 pandemic on other respiratory infections and highlight the important insights that can be gained from viral genomes.

Nature CommunicationsVol. 15(1)
St. Jude Children's Research Hospital (US), University of Auckland (NZ), Hutt Hospital (NZ), Counties Manukau District Health Board (NZ), Capital and Coast District Health Board (NZ), New Zealand Institute for Public Health and Forensic Science (NZ), Massey University (NZ), University of Otago (NZ)
University of Otago, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 9%
Respiratory viral infections research
2.71
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.